Global Cardiac POC Testing Devices Market Overview And Scope:
Global Cardiac POC Testing Devices Market Size was estimated at USD 2473.98 million in 2022 and is projected to reach USD 3481.27 million by 2028, exhibiting a CAGR of 5.86% during the forecast period.
The Global Cardiac POC Testing Devices Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Cardiac POC Testing Devices utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Roche Diagnostics, Abaxis, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, Siemens HealthCare Diagnostics
Global Cardiac POC Testing Devices Market Segmentation
By Type, Cardiac POC Testing Devices market has been segmented into:Troponin test
Brain natriuretic peptide test
Others
By Application, Cardiac POC Testing Devices market has been segmented into:
Clinics
Hospitals
Laboratories
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Cardiac POC Testing Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Cardiac POC Testing Devices market.
Top Key Players Covered in Cardiac POC Testing Devices market are:
Roche Diagnostics
Abaxis
Abbott
Beckman Coulter
Beckton and Dickinson
Bayer Diabetes Care
Hemocue AB
International Technidyne Corporation
LifeScan Inc
Nipro Diagnostics
Orasure Technologies
PointCare Technologies
Siemens HealthCare Diagnostics
Objective to buy this Report:
1. Cardiac POC Testing Devices analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Cardiac POC Testing Devices market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Cardiac POC Testing Devices Market by Type
5.1 Cardiac POC Testing Devices Market Overview Snapshot and Growth Engine
5.2 Cardiac POC Testing Devices Market Overview
5.3 Troponin test
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Troponin test: Geographic Segmentation
5.4 Brain natriuretic peptide test
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Brain natriuretic peptide test: Geographic Segmentation
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation
Chapter 6: Cardiac POC Testing Devices Market by Application
6.1 Cardiac POC Testing Devices Market Overview Snapshot and Growth Engine
6.2 Cardiac POC Testing Devices Market Overview
6.3 Clinics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Clinics: Geographic Segmentation
6.4 Hospitals
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospitals: Geographic Segmentation
6.5 Laboratories
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Laboratories: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Cardiac POC Testing Devices Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Cardiac POC Testing Devices Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Cardiac POC Testing Devices Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ROCHE DIAGNOSTICS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ABAXIS
7.4 ABBOTT
7.5 BECKMAN COULTER
7.6 BECKTON AND DICKINSON
7.7 BAYER DIABETES CARE
7.8 HEMOCUE AB
7.9 INTERNATIONAL TECHNIDYNE CORPORATION
7.10 LIFESCAN INC
7.11 NIPRO DIAGNOSTICS
7.12 ORASURE TECHNOLOGIES
7.13 POINTCARE TECHNOLOGIES
7.14 SIEMENS HEALTHCARE DIAGNOSTICS
Chapter 8: Global Cardiac POC Testing Devices Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Troponin test
8.2.2 Brain natriuretic peptide test
8.2.3 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Clinics
8.3.2 Hospitals
8.3.3 Laboratories
8.3.4 Others
Chapter 9: North America Cardiac POC Testing Devices Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Troponin test
9.4.2 Brain natriuretic peptide test
9.4.3 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Clinics
9.5.2 Hospitals
9.5.3 Laboratories
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Cardiac POC Testing Devices Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Troponin test
10.4.2 Brain natriuretic peptide test
10.4.3 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Clinics
10.5.2 Hospitals
10.5.3 Laboratories
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Cardiac POC Testing Devices Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Troponin test
11.4.2 Brain natriuretic peptide test
11.4.3 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Clinics
11.5.2 Hospitals
11.5.3 Laboratories
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Cardiac POC Testing Devices Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Troponin test
12.4.2 Brain natriuretic peptide test
12.4.3 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Clinics
12.5.2 Hospitals
12.5.3 Laboratories
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Cardiac POC Testing Devices Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Troponin test
13.4.2 Brain natriuretic peptide test
13.4.3 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Clinics
13.5.2 Hospitals
13.5.3 Laboratories
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Cardiac POC Testing Devices Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Troponin test
14.4.2 Brain natriuretic peptide test
14.4.3 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Clinics
14.5.2 Hospitals
14.5.3 Laboratories
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Cardiac POC Testing Devices Scope:
|
Report Data
|
Cardiac POC Testing Devices Market
|
|
Cardiac POC Testing Devices Market Size in 2025
|
USD XX million
|
|
Cardiac POC Testing Devices CAGR 2025 - 2032
|
XX%
|
|
Cardiac POC Testing Devices Base Year
|
2024
|
|
Cardiac POC Testing Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche Diagnostics, Abaxis, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, Siemens HealthCare Diagnostics.
|
|
Key Segments
|
By Type
Troponin test
Brain natriuretic peptide test
Others
By Applications
Clinics
Hospitals
Laboratories
Others
|
